Summary
- Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine, Comirnaty, targeting the KP.2 subvariant of Omicron.
- Provinces were asked to dispose of older vaccines to ensure the most current version is used during the fall respiratory virus season.
- Comirnaty joins Moderna’s Spikevax and Novavax’s Nuvaxovid as updated vaccines approved by Health Canada this season.
- Pfizer and Moderna vaccines are approved for adults and children six months and older, while Novavax is for adults and children 12 years and older.